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ABSTRACT
Background Cerebral blood ﬂow velocity (CBFV) and
sleep physiology in healthy children exposed to hypoxia
and hypocarbia are under-researched.
Aim To investigate associations between sleep
variables, daytime end-tidal carbon dioxide (EtCO2) and
CBFV in children during high-altitude ascent.
Methods Vital signs, overnight cardiorespiratory sleep
studies and transcranial Doppler were undertaken in nine
children (aged 6–13 years) at low altitude (130 m), and
then at moderate (1300 m) and high (3500 m) altitude
during a 5-day ascent.
Results Daytime (130 m: 98%; 3500 m: 90%,
p=0.004) and mean (130 m: 97%, 1300 m: 94%,
3500: 87%, p=0.0005) and minimum (130 m: 92%,
1300 m: 84%, 3500 m: 79%, p=0.0005) overnight
pulse oximetry oxyhaemoglobin saturation decreased,
and the number of central apnoeas increased at altitude
(130 m: 0.2/h, 1300 m: 1.2/h, 3500 m: 3.5/h, p=0.2),
correlating inversely with EtCO2 (R
2 130 m: 0.78;
3500 m: 0.45). Periodic breathing occurred for median
(IQR) 0.0 (0; 0.3)% (130 m) and 0.2 (0; 1.2)%
(3500 m) of total sleep time. At 3500 m compared with
130 m, there were increases in middle (MCA) (mean (SD)
left 29.2 (42.3)%, p=0.053; right 9.9 (12)%, p=0.037)
and anterior cerebral (ACA) (left 65.2 (69)%, p=0.024;
right 109 (179)%; p=0.025) but not posterior or basilar
CBFV. The right MCA CBFV increase at 3500 m was
predicted by baseline CBFV and change in daytime SpO2
and EtCO2 at 3500 m (R
2 0.92); these associations were
not seen on the left.
Conclusions This preliminary report suggests that sleep
physiology is disturbed in children even with slow ascent
to altitude. The regional variations in CBFV and their
association with hypoxia and hypocapnia require further
investigation.
INTRODUCTION
Sleep disordered breathing (SDB) is reported in accli-
matised and non-acclimatised adults sleeping at alti-
tude.1 2 Despite frequent exposure and concerns over
developmental effects,3 there are limited data from
children,2 particularly during slow acclimatisation.
Nocturnal breathing is inﬂuenced by the delicate
chemoreceptor balance affected by sleep stage.4 The
central medullary chemoreceptors respond to hydro-
gen ion concentration [H+], altered by partial pres-
sure of carbon dioxide (pCO2) via the cerebrospinal
ﬂuid (CSF) bicarbonate buffering system, and by
changing cerebral blood ﬂow (CBF).5 6 The carotid
body peripheral chemoreceptors respond to pO2 as
well as pCO2 and pH.
6 There is a hypoxic ventilatory
response (HVR) at pO2 <60 mmHg, but in place of
the normoxic hypercapnic drive, the hyperventilation
leads to hypocapnia, reducing the change in pCO2
required to reach the apnoea threshold,7 around
which oscillations of pulse oximetry oxyhaemoglobin
saturation (SpO2) and pCO2 are associated with peri-
odic breathing.1 8
Transcranial Doppler (TCD) measurement of
change in CBF velocities (CBFV) can assess
regional perfusion change.9 At sea level, with
Open Access
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What is already known on this topic
▸ Children have less periodic breathing in sleep
than adults, after rapid ascent to 3500 m,
despite similar mean and minimum overnight
oxygen saturations (SpO2) and pCO2.
▸ At sea level, cerebral blood ﬂow velocity
(CBFV) is directly dependent on pCO2, but in
normocarbic adults, CBFV increases at
SpO2<90%.
▸ Increased CBFV is seen in young children with
sleep-disordered breathing, and may reverse in
association with improved overnight oxygen
saturation after adenotonsillectomy.
What this study adds
▸ Low oxygen saturation (SpO2) is conﬁrmed in
sleeping children at altitude, and periodic
breathing is related to pCO2.
▸ SpO2 and pCO2 reduction and cerebral blood
ﬂow velocity (CBFV) increase at altitude are
lower if sea level right middle cerebral artery
CBFV is higher, suggesting interaction with
hypoxic hyperventilatory response.
▸ In acute hypoxia, cerebral oxygen delivery is
maintained by an increase in CBFV anteriorly,
but may fall posteriorly.
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SpO2>97%, there is a linear relationship between middle cere-
bral (MCA) and basilar (BA) CBFV and pCO2 between 20 and
60 mm Hg,6 9 10 also mediated via local [H+]. However,
although CBFV typically increases when SpO2 is <90%,
11 the
response to hypoxia is variable between subjects12 13 and within
subjects, both regionally12 14 15 and diurnally.16 Technical
advances now allow informative portable physiological record-
ing at altitude, overcoming many prior difﬁculties in studying
healthy children.
The purpose of this Smiths Medical Young Everest Study17
was to document natural sleep and daytime CBFV after gradual
ascent to 3500 m in comparison with data collected at 130 m,
to explore the effects of change in daytime end-tidal (Et) pCO2
and SpO2 and overnight SpO2 on sleep physiology and daytime
regional cerebral circulation, and to determine if
altitude-induced sleep difﬁculties would impact on episodic
memory recall.18
METHODS
Children were recruited from families undertaking a trekking
holiday in Nepal17; none had recently travelled to altitudes
>1000 m. The study was approved by the UCL research ethics
committee (ID:0894/001), and informed written assent/consent
obtained from children and their parents. Baseline measure-
ments were undertaken by ﬁve specialists in paediatric respira-
tory and sleep physiology/medicine at ≤130 m in England, and
during slow graded ascent (5 days from sea level to 3500 m),
planned to maximise safety and minimise acute mountain sick-
ness risk.17 19 Intermediate altitude studies were performed at
Kathmandu (1300 m). After ﬂying to Lukla (2670 m), the chil-
dren trekked for 2 days, sleeping one night at 2650 m and the
next at 2835 m, before ascending to Namche Bazaar (3500 m)
on the third trek day (day 5 from sea level) where the high-
altitude studies were undertaken. With the exception of the
sleep studies, recordings were made in a research laboratory
setting between 10:00 and 14:00 the day after arrival.17
Sleep studies
Cardiorespiratory sleep studies (LS-100 LifeShirts, Vivometrics,
USA) recorded overnight SpO2, ECG, body position, and
abdominal and thoracic respiratory effort via inductance
plethysmography, but not nasal airﬂow. Overnight studies were
recorded over the ﬁrst two nights following arrival. Data from
the ﬁrst 6 h of sleep were analysed using paediatric industry
standards (eg, 3% oxygen desaturations).
Daytime recordings of vital signs
Daytime SpO2, EtCO2, heart rate (HR), Respiratory Rate (RR)
(Tidal Wave 710 Monitor, Respironics, Pennsylvania, USA) and
blood pressure were recorded.17
Cerebral blood ﬂow velocity
CBFV was measured by JCG and/or FJK, using TCD (EZ-Dop,
DWL, Germany) in the BA and right and left MCA and anterior
(ACA) and posterior (PCA) cerebral arteries, each located
according to a previously described protocol for which the coef-
ﬁcient of variation was 7%.20 Highest time-averaged maximum
mean CBFV (cm/s) was reported over at least six cardiac cycles,
analysed blind to subject and altitude. Assuming stable haemo-
globin and vessel diameter, proportional change in cerebral
oxygen delivery (COD) from baseline at altitude (Alt) compared
with sea level (Sea) was calculated using the formula21:
ChangeCOD ¼ ½ððAltSpO2  AltCBFVÞ  ðSeaSpO2
 SeaCBFVÞÞ=ðSeaSpO2  SeaCBFVÞ
Memory
Rivermead Memory Test story recall was used at all three alti-
tudes to determine the ability to recall a short story immediately,
and after a delay.22
Statistical analysis
Descriptive statistics are reported at all three altitudes. Variables
were examined for normality and non-parametric descriptives
and statistical tests selected. Between altitude (130 m, 1300 m,
3500 m) and hemisphere (left, right) comparisons were con-
ducted using paired samples t tests, or Wilcoxon’s for two mea-
sures, and repeated measures analysis of variance (ANOVA), or







High altitude %Δ from
sea p Value
Mean daytime oxygen saturation (SpO2; %)* 98 (98, 99) NA 90 (87, 91)† −9.17 (2.1) 0.004
Mean overnight oxygen saturation (SpO2; %)* ‡
§
97 (96, 98) 94 (92, 97)† 87(85, 88)† ¶ −11.1 (2.9) <0.0005
Minimum oxygen saturation (SpO2; %)* ‡ 92 (89, 93) 84 (78, 94)* 79 (76, 80)† ¶ −14.4 (7.7) <0.0005
Number of oxygen desaturations per hour* ‡ 0.2 (0, 1.2) 4.9 (2, 12)* 10.0 (4, 22)† ¶ <0.0005
Number of central apnoeas per hour* ** 0.2 (0, 1.2) 1.2 (0.7, 3.2) 3.5 (1.1, 5.7)† 0.2
Periodic breathing (% TST)* ** 0.0 (0, 0.3) 0 (0, 1.2) 0.2 (0, 1.15)† 0.5
Daytime EtCO2 (mmHg) 42.7 (40, 45) NA 36.0 (34, 38)† −16 (5.1) 0.004
Daytime respiratory rate (breaths per min) 21 (20, 24) NA 23 (22, 26)† 8.2 (7.0) 0.01
Daytime heart rate (bpm) 78 (72, 85) NA 97 (87, 109)† 26.7 (16.3) 0.004
*For the sleep and respiratory variables, transformation did not redress distributional problems, so data are presented as median and IQR (25th and 75th centiles), and were compared
using Wilcoxon signed-rank test where there were no data at mid-altitude, or Friedman’s ANOVA where data were available at all three altitudes, with posthoc testing using the
Wilcoxon signed-rank test. p Values refer to significant change across all three altitudes.
†Significantly different from 130 m.
‡(η2) for mean overnight oxygen saturation=16.2, for minimum oxygen saturation=13.8 and for number of oxygen desaturations per hour=16.2.
§n=7 at moderate altitude.
¶Significantly different from 1300 m.
**n=3 at moderate altitude, n=8 at high altitude.
EtCO2, end-tidal pCO2; TST, total sleep time; NA, equipment failure.
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Friedman’s ANOVA for three. Paired t tests or Wilcoxon
signed-rank test and an appropriate Bonferroni correction were
used for posthoc testing. Linear regression was used to examine
the degree of association for continuous variables. Analysis was




Nine children (5 boys) aged 6–13 years (mean age 8.8, SD 2.4),
all right-handed and remaining well, were studied.17 Lung func-
tion remained within 7% of sea level baseline in all but two.17
All sleep studies at 130 m and 3500 m, but only seven at
1300 m, recorded at least 6 h of high-quality data (table 1).
Respiratory and sleep measures
Mean SpO2 was higher during daytime than overnight at 130 m
and 3500 m (table 1). With increasing altitude, daytime and
overnight mean SpO2 and EtCO2 decreased (table 1). Daytime
RR and HR increased signiﬁcantly (table 1). Compared with
baseline, overnight SpO2 decreased signiﬁcantly, both in terms
of overall mean, and in the minimum reached overnight, while
the number of oxygen desaturations increased (table 1). Despite
no overall difference in the number of central apnoeas or
percentage of total sleep time spent in periodic breathing across
the three altitudes, on posthoc testing, there were signiﬁcant dif-
ferences between 130 m and 3500 m (table 1). Daytime and
mean overnight SpO2 were inversely correlated with daytime
EtCO2 at 3500 m but not at 130 m (ﬁgure 1A,B; table 2), while
minimum overnight SpO2 was weakly positively and inversely
correlated with daytime EtCO2 at 150 m and 3500 m, respect-
ively (ﬁgure 1C). The number of desaturations/hour and per-
centage of sleep spent in periodic breathing correlated with
daytime EtCO2 at 130 m but not at 3500 m (ﬁgures 1D,F; table
2). The number of central apnoeas/hour was higher in those
with lower daytime EtCO2 both at 130 and at 3500 m (ﬁgure
1E). Mean overnight SpO2 (range 80–89%) was signiﬁcantly
correlated (R2 0.51, p=0.03) with daytime values (range 85–
92%) at 3500 m, whereas, there was no correlation (R2 0.04,
p=0.6) at 130 m.
Transcranial Doppler
There were signiﬁcant increases in CBFV in the left MCA and
both ACAs at 3500 m compared with 130 m (table 3, ﬁgure 2).
Left MCA velocities were lower than right at sea level, and
increased more at altitude (table 3).23 There were no signiﬁcant
velocity changes in the PCA or BA. With the exception of the
BA, calculated COD increased in all arteries. There was no
Figure 1 Effect of daytime end-tidal carbon dioxide on other respiratory measurements. (a) Daytime haemoglobin oxygen saturation (SpO2, %); (b)
mean overnight SpO2; (d) number of desaturations per hour; (e) number of central apnoeas per hour; (f ) percentage of total sleep time in periodic
breathing each plotted against daytime end-tidal partial pressure of carbon dioxide (pCO2) for the nine children studied at 130 m (crosses) and
3500 m (open triangles); (c) relationship between mean overnight and daytime SpO2. Mean overnight SpO2 was signiﬁcantly correlated (R
2 0.49,
p=0.035) with daytime values at 3500 m (Δ), whereas there was no correlation (R2 0.04, p=0.626) at 130 m (x).
Table 2 Relationship between daytime EtCO2, daytime SpO2 and sleep variables at baseline (130 m) and altitude (3500 m)
130 m 3500 m
EtCO2=38–47 mm Hg Daytime EtCO2=31–40 mm Hg
R2 p Value β Range R2 p Value β Range
Daytime SpO2 (%) 0.32 0.1 −0.561 97–100 0.65 0.009 −0.806 85–92
Mean overnight SpO2 (%) 0.12 0.4 0.353 96–98 0.40 0.066 −0.635 80–89
Minimum overnight SpO2 (%) 0.46 0.046 0.675 84–94 0.38 0.078 −0.615 60–82
Number of desaturations/hour overnight 0.75 0.003 −0.865 0–1.7 0.16 0.3 0.398 0.7–49.3
Number of central apnoeas/hour overnight 0.78 0.002 −0.882 0–1.7 0.45 0.047 −0.673 0.3–9.5
% total sleep time spent in periodic breathing 0.76 0.017 −0.763 0–0.4 0.27 0.15 −0.159 0–17.5
EtCO2, end-tidal partial pressure of carbon dioxide; SpO2, haemoglobin oxygen saturation from pulse oximeter.
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correlation between change in BA velocity and change in central
apnoeas or percentage periodic breathing between 130 and
3500 m.
Daytime SpO2 and MCA velocities
An exploratory multiple regression analysis was built to predict
right MCA CBFV at 3500 m, entering baseline right MCA
CBFV at 130 m (step 1), daytime SpO2 at 3500 m as a percent-
age of daytime SpO2 at 130 m (step 2) and EtCO2 at 3500 m as
a percentage of EtCO2 at 130 m (step 3). Right MCA CBFV at
130 m was not a signiﬁcant predictor of right MCA CBFV at
3500 m (R2 0.2, p=0.225). However, a model with right MCA
CBFV at 130 m and daytime SpO2 at 3500 m as a percentage of
SpO2 at 130 m was signiﬁcant, with both right MCA CBFV at
130 m (β 0.91 (95% CI 0.46 to 1.59), p=0.004), and change in
daytime SpO2 (β −0.91 B −4 (95% CI −6.7 to −1.9),
p=0.007), as signiﬁcant predictors (R2 change 0.60; p=0.006,
F[2,8]=1.79; p=0.008). EtCO2 at 3500 m as a percentage of
EtCO2 at 130 m also contributed signiﬁcant variance to right
MCA CBFV at 3500 m (R2 change=0.13; p=0.034; F[3,8]
=20.21; p=0.003). Together, these three variables explained
92% of the variance in right MCA CBFV at 3500 m. Change in
HR was not a signiﬁcant predictor. Inspection of the β weights
revealed that increase in right MCA CBFV and greater reduction
in SpO2 and EtCO2 between 130 m and 3500 m signiﬁcantly
predicted right MCA CBFV at 3500 m. Sea level right MCA
CBFV was not predictive until SpO2 changes were entered into
the model, consistent with an interaction between individual dif-
ferences in right MCA CBFV and the degree to which SpO2 and
EtCO2 were compromised at altitude. The residuals were nor-
mally distributed, consistent with good model ﬁt to the data.
For left MCA and BA velocities, none of the models were
signiﬁcant.
Memory
There were no differences between Rivermead scores at the
three altitudes.
DISCUSSION
Respiratory and sleep physiology
Prior to this expedition, data on the effects of altitude on
daytime and/or sleep physiology in children sojourning at alti-
tude were lacking. This study appears to show that children
have similar physiological responses to altitude as those
recorded previously in adults,1 2 but have less central apnoeas24
and periodic breathing.2 The number of central apnoeas, and
percentage of periodic breathing in sleep, increased at high alti-
tude, with concurrent increases in the number and severity of
oxygen desaturations. EtCO2 was associated with the number of
central apnoeas at 130 m, suggesting that at normoxia in chil-
dren, the baseline degree of hypocapnia may determine whether
the apnoea threshold is reached. At 3500 m, as in adults,24 the
relationship was still signiﬁcant, but without overnight EtCO2
measurement, we could not determine the EtCO2 at which
apnoeas were triggered.2 Daytime HR increased signiﬁcantly
(table 1), consistent with a 24% increase in cardiac output
assuming no change in stroke volume.
Our results support previous ﬁndings of low nocturnal SpO2
at altitude in both native25 26 and non-acclimatised children,2 27
and illuminate the associated SDB patterns. The severity of
hypoxia, hypoventilation and periodic breathing experienced at
high altitude exacerbates sleep fragmentation, with recent evi-
dence that hypoxia is the most important factor,28 but our study
is in line with previous literature showing no effect on episodic
memory.29 Mean daytime and overnight SpO2 decreased at high
altitude, despite increases in RR and decreases in EtCO2 com-
patible with an intact HVR.




Moderate altitude (1300 m)





% Change from low altitude
Mean (SD)









Left 69.1 (12.5) 35.2 (33.4)1 29.2 (42.3)2 4.2 (19.3) 18.7 (44.0)
Right 84.0 (8.4) 7.2 (11.4) 9.9 (12.0) 3.0 (10.9) 1.9 (7.5)
ACA*
(n=7)
Left 45.3 (13.2) 43.4 (53.4) 65.2 (69.0)2 28.3 (42.7) 47.8 (60.4)
Right 51.1 (22.4) 94.1 (159.7) 109.1 (179.2)2 13.5 (34.4) 41.6 (68.7)
PCA*$
(n=7)
Left 37.4 (11.2) 40.5 (71.0) 49.9 (75.0) 15.1 (35.4) 34.9 (65.6)
Right 38.7 (6.2) 21.1 (43.9) 17.5 (33.5) 6.4 (29.4) 12.6 (25.7)
BA* (n=9) 53.2 (12.6) 4.5 (16.4) 9.5 (21.8) 4.9 (14.0) −1.3 (19.0)
Percentage change in COD was calculated using the following formula: ((AltSPo2×AltCBFV)−(SeaSpo2×SeaCBFV))/(SeaSpo2×SeaCBFV) where: AltSpo2 is the SpO2 value at altitude;
AltCBFV is the CBFV at altitude; SeaSpO2 is the SpO2 at sea level; and sea CBFV is the CBFV at sea level, and haemoglobin is assumed to be constant.
There were significant effects of hemisphere, F(1,8)=10.66, p=0.011, η2=0.57 and of altitude, F(2,7)=5.08, p=0.043, η2=0.59 on maximum MCA velocities, and a significant
interaction, F (2,7)=5.33, p=0.039, η2=0.60. Inspection of table 3 reveals that CBFV in the MCA significantly increased at moderate and high altitude, compared with sea level, to a
greater degree in the left than in the right hemisphere.
Although inspection of table 3 shows that CBFV appeared to increase within the ACA, both left and right, this just failed to reach significance despite a large effect, F(2,5)=5.28,
p=0.059, η2=0.68, likely due to the small N, a finding confirmed by posthoc, pairwise comparisons which revealed significant increases in ACA CBFV in both hemispheres from low to
high altitude. There were no significant effects of hemisphere or altitude on PCA, and no effect of altitude in the BA, all F<2.3.
Data are presented as mean or geometric mean (SD), velocities are reported as cm/s; 1=significant between groups difference between low and moderate altitude; 2=between low and
high altitude.
$PCA values were transformed for the analysis using the natural logarithm; however, the mean (SD) values are provided for ease of interpretation.
*Middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), basilar artery (BA).
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Change in CBFV and COD in anterior and posterior
circulations
To our knowledge, this study is the ﬁrst to examine regional
TCD velocities in children unaccustomed to high altitudes in
relation to daytime respiratory variables and sleep. Exposure to
hypoxia and hypocapnia has conﬂicting effects on cerebral per-
fusion. In adults residing at altitude, the cerebral circulation
appears less sensitive to hypoxia than to hypocapnia,30 but
CBFV increases with decreasing pO2 at altitude in adults resi-
dent at sea level and in hypoxic adults at sea level, with no evi-
dence for an effect of EtCO2.
31 32 In our data, right MCA
CBFV was generally higher than left, consistent with increased
CBF to a larger hemisphere.33 Although there was considerable
variability,12 left MCA and both ACA velocities increased, with
increased calculated COD even assuming no increase in haemo-
globin. However, BA and PCA velocities did not increase signiﬁ-
cantly.14 In elite climbers, basilar CBFV reduces at altitude,13
perhaps allowing build up of CO2 and, therefore, unstable
breathing.6 34 Although in our data the change in basilar vel-
ocity was not associated with change in central apnoeas or peri-
odic breathing, this could be further explored in overnight
studies. Calculated COD appears to fall in the basilar distribu-
tion on exposure to high altitude,35 which may be related to
reduced metabolic rate, but might increase the risk of comprom-
ise to the parieto-occiptal cerebellar brain tissues associated with
the common complaints of nausea, dizziness, ataxia and visual
symptoms.36
Asymmetry in haemodynamic response
In humans native to high altitude, CBFV changes in response to
isocapnic hypoxia may show regional brain differences,12 37 38
but there are few data in children resident at sea level exposed
to hypocapnic hypoxia. Although we lacked direct measure-
ments of blood gases, the increase in RR and decrease in pCO2
suggests a response to hypoxia in this study, and there appears
to be an interaction between baseline right MCA CBFV and
change in day (and night-time) SpO2 and daytime EtCO2 in pre-
dicting 92% of the variance in high-altitude right MCA CBFV.
This is consistent with the interaction between right MCA
CBFV and the hypercapnic ventilatory response previously
documented at sea level in healthy adults.5 In turn, this means
that the degree of desaturation and hypocapnia at altitude is less
and, therefore, the change in right MCA CBFV is less if right
MCA CBFV is higher at sea level. Most adult studies have only
reported right MCA CBFV, but Feddersen, who examined the
left MCA, also found asymmetry.39 There is evidence that the
right hemisphere controls neural sympathetic outﬂow, with a
possible interaction with pCO2,
40 but the direction and lateral-
isation of the association we have demonstrated requires further
investigation, including direct measurement of blood gases.
Control of change in CBFV on exposure to hypocapnic
hypoxia at altitude
In line with previous data in adults, our data suggest the import-
ance of oxygen content in the regulation of the ACA circulation,
so that at altitude, in children resident at sea level, CBF, for
which CBFV is a proxy, increases in response to hypoxaemia,32
even when there is hypocapnia.30
Limitations
MCA diameter may increase on acute exposure to 12% hypoxia
or at extreme altitude (>5300).41 In our study, the children
made a slow ascent to 3500 m, and cerebral artery diameters
were assumed to be unchanged, as is also the case with SpO2 as
low as 70% at sea level.38 A change of <10% in arterial diam-
eter was recorded with EtCO2 as low as 20 mm Hg in adults.
38
Future studies should check the assumption that vascular diam-
eter does not change over these ranges, and should look at
regional cerebral perfusion variations and diurnal variation of
CBF in relation to EtCO2 and breathing instability in various
sleep stages, determined using EEG, to determine whether clin-
ically relevant differences occur. In addition, recording pH, for
instance, in urine, would be important, provided validation
compared with blood measurements, which are difﬁcult to
justify on ethical grounds, is achieved. In combination with
serial CBFV measurements, this would allow exploration of the
metabolic compensation to hypocapnia, which occurs in the
ﬁrst 2–3 days after arrival at altitude, involving renal loss of
serum bicarbonate, as well as reduction in CSF bicarbonate
production, thereby minimising the deviation of arterial and
CSF pH.
Figure 2 Velocities in the left and
right middle, anterior, posterior and
basilar arteries at 130 m, 1350 m and
3500 m in nine children resident at sea
level.
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In summary, our preliminary data conﬁrm that healthy chil-
dren resident at sea level, and exposed to high altitudes during a
slow ascent to 3500 m, experience periodic breathing and
further haemoglobin oxygen desaturation during sleep. SpO2
and EtCO2 appear to be important determinants of the increase
in right-sided MCA CBFV that occurs on exposure to altitude.
Despite hypocapnia, this study demonstrates for the ﬁrst time in
children that there is an increase in CBFV at altitude, adequate
to preserve COD in the distribution of all vessels but the BA.
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